Presentation TCT 2021 Beyond Guidelines – Novel Approaches to Achieve Evidence-Based Practice Presenter: Catherine Otto November 04, 2021 REGISTER for free or LOG IN to view this content Policy & Practice TCT 2021 Guidelines Up Next Presentation TCT 2021 RADIANCE-HTN: Six-Month Outcomes of a Randomized Trial of Renal Denervation Versus a Sham Procedure for Resistant Hypertension – Impact of Treatment-Blinded Medication Titration Presenter: Ajay Kirtane November 04, 2021 More slides + Presentation TCT 2021 Adapting Clinical Trials to a Black Swan Event, from the FDA Perspective Presenter: Andrew Farb November 04, 2021 Presentation TCT 2021 Adapting Clinical Trials to a Black Swan Event, from Industry Perspective Presenter: Sandeep Brar November 04, 2021 We Recommend Disclosures Nothing to disclose
Presentation TCT 2021 RADIANCE-HTN: Six-Month Outcomes of a Randomized Trial of Renal Denervation Versus a Sham Procedure for Resistant Hypertension – Impact of Treatment-Blinded Medication Titration Presenter: Ajay Kirtane November 04, 2021
Presentation TCT 2021 Adapting Clinical Trials to a Black Swan Event, from the FDA Perspective Presenter: Andrew Farb November 04, 2021
Presentation TCT 2021 Adapting Clinical Trials to a Black Swan Event, from Industry Perspective Presenter: Sandeep Brar November 04, 2021